Skip to main content

Surface Oncology, Inc.

SURFDelisted Sep 8, 2023
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001718108

Surface Oncology, Inc. was delisted on Sep 8, 2023; its insiders filed their last Form 4 on Sep 8, 2023; 62 institutions reported holding it in 13F filings for Q2 2023, worth $16.9M in total; ARK Invest was the only superinvestor holding it.

Q3 2022 vs. Q2 2022

How the institutions holding Surface Oncology, Inc. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of SURF: Q2 2022 compared with Q3 2022
MeasureQ2 2022Q3 2022Change
Holders8580−5
Shares28.9M31.6M+2.69M (+9.3%)
Value$48.6M$32.8M−$15.8M (−32.5%)

New holders (9)

Institutions that held Surface Oncology, Inc. at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to SURF in Q3 2022
InstitutionSharesValue% of portfolio
Sumitomo Mitsui Trust Holdings, Inc.1,104,230$1.15M0.00%
Nikko Asset Management Americas, Inc.1,104,230$1.10M0.01%
Connor, Clark & Lunn Investment Management Ltd.98,062$102.0K0.00%
Man Group plc13,400$14.0K0.00%
Balyasny Asset Management LLC10,632$11.0K0.00%
Simplex Trading, LLC3,931$4.00K0.00%
Federated Hermes, Inc.1,152$1.00K0.00%
Larson Financial Group LLC751$1.00K0.00%
China Universal Asset Management Co., Ltd.544$1.00K0.00%

Sold out (14)

Institutions that held Surface Oncology, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.